2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)
Clinical trial NCT00090246 · COMPLETED
Trial details
- NCT number
- NCT00090246
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-13
- Primary completion
- 2005-04-06
- Enrollment
- 922
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.